AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30303900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study 27143871 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1,800 mg twice daily for 8 weeks
Number of subjects: 51
Study 27143871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 27143871 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 51
Study 24495355 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo Synergy(®) plus Choline
Number of subjects: 97
Study 24495355 — intervention group
Group type: EXPERIMENTAL
Intervention: OPC Synergy(®) plus Catalyn(®)
Number of subjects: 97
Study 22104034 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline (0 months)
Number of subjects: 3
Study 22104034 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up (6 months)
Number of subjects: 3
Study 20457582 — intervention group
Group type: COMPARATOR
Intervention: RPE group (Hyrax screws activated every 12 hours for 1 week)
Number of subjects: 30
Study 20457582 — intervention group
Group type: EXPERIMENTAL
Intervention: A/D-RPE group (Hyrax screws activated every 12 hours for 1 week, then deactivated every 12 hours for 1 week, followed by activation and deactivation for 2 weeks)
Number of subjects: 30
Study 20457582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (RPE and A/D-RPE)
Number of subjects: 30
Study 17714055 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT) doses of 200-1080 microg in Study 1
Number of subjects: 70
Study 17714055 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT) doses of 270-1300 microg in Study 2
Number of subjects: 70
Study 16236802 — intervention group
Group type: COMPARATOR
Intervention: 40% CNI reduction plus mycophenolate mofetil (group 1)
Number of subjects: 84
Study 16236802 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate CNI withdrawal and rapamycin introduction (group 2)
Number of subjects: 84
Study 12404691 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.5 g/kg
Number of subjects: 13
Study 12404691 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.3 g/kg
Number of subjects: 13
Study 12404691 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.8 g/kg
Number of subjects: 13
Study 12404691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 9834924 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral formula enriched with arginine, omega‐3 fatty acids, and RNA administered 7 days before and 7 days after surgery
Number of subjects: 30
Study 9834924 — intervention group
Group type: COMPARATOR
Intervention: Same diet but only 7 days after surgery
Number of subjects: 30
Study 8129116 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Mobilization Group
Number of subjects: 82
Study 8129116 — intervention group
Group type: COMPARATOR
Intervention: Immobilization Group
Number of subjects: 82
Study 2659296 — intervention group
Group type: EXPERIMENTAL
Intervention: aztreonam + clindamycin
Number of subjects: 110
Study 2659296 — intervention group
Group type: EXPERIMENTAL
Intervention: tobramycin + clindamycin
Number of subjects: 110
Study 2659296 — intervention group
Group type: EXPERIMENTAL
Intervention: amikacin + mezlocillin
Number of subjects: 110
Study 5792611 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary concentrating ability assessment during 24 hours' deprivation of fluids
Number of subjects: 0
Study 5792611 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of maximum urinary osmolality
Number of subjects: 0
Study 30590973 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 50
Study 29191188 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectations scale
Number of subjects: 384
Study 29191188 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 384
Study 25638568 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric corticotomy
Number of subjects: 30
Study 25638568 — intervention group
Group type: COMPARATOR
Intervention: Conventional orthodontic traction
Number of subjects: 30
Study 25638568 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 22377778 — intervention group
Group type: EXPERIMENTAL
Intervention: simplified modified Rankin Scale questionnaire (smRSq)
Number of subjects: 150
Study 22377778 — intervention group
Group type: EXPERIMENTAL
Intervention: conventional modified Rankin Scale (mRS)
Number of subjects: 150
Study 22377778 — intervention group
Group type: EXPERIMENTAL
Intervention: comparison between mRS and smRSq
Number of subjects: 150
Study 22377778 — intervention group
Group type: EXPERIMENTAL
Intervention: NIH Stroke Scale (NIHSS)
Number of subjects: 150
Study 20357376 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone outreach with speech recognition (ATO-SR)
Number of subjects: 1200
Study 20357376 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no intervention)
Number of subjects: 1200
Study 18383334 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine challenge (PC20 < or = 4.0 mg/ml) in girls
Number of subjects: 640
Study 18383334 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine challenge (PC20 < or = 8.0 mg/ml) in nonatopic girls
Number of subjects: 640
Study 18383334 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine challenge (PC20 < or = 2.0 mg/ml) in atopic boys
Number of subjects: 640
Study 18383334 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine challenge in nonatopic boys
Number of subjects: 640
Study 18383334 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine challenge in atopic girls
Number of subjects: 640
Study 18383334 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine challenge in nonatopic girls
Number of subjects: 640
Study 16027564 — intervention group
Group type: EXPERIMENTAL
Intervention: NDB-derived activities
Number of subjects: 30
Study 16027564 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched to interest only activities
Number of subjects: 30
Study 16027564 — intervention group
Group type: COMPARATOR
Intervention: Matched to skill level only treatment
Number of subjects: 30
Study 16027564 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 30
Study 12453948 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide GITS (maximum 20 mg)
Number of subjects: 91
Study 12453948 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (maximum 2,550 mg)
Number of subjects: 91
Study 12453948 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (glipizide GITS + metformin)
Number of subjects: 91
Study 10361626 — intervention group
Group type: EXPERIMENTAL
Intervention: Elcometrine
Number of subjects: 135
Study 10361626 — intervention group
Group type: COMPARATOR
Intervention: Copper-T380 IUD
Number of subjects: 135
Study 7556039 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise for 10 min
Number of subjects: 80
Study 7556039 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise for 25 min
Number of subjects: 80
Study 7556039 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise for 40 min
Number of subjects: 80
Study 7556039 — intervention group
Group type: COMPARATOR
Intervention: Attention control for 10 min
Number of subjects: 80
Study 2147787 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva stimulants (V6 chewing gum)
Number of subjects: 106
Study 2147787 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva stimulants (Salivin lozenge)
Number of subjects: 106
Study 2147787 — intervention group
Group type: EXPERIMENTAL
Intervention: All eight tested saliva stimulants and substitutes
Number of subjects: 106
Study 2147787 — intervention group
Group type: EXPERIMENTAL
Intervention: All eight products
Number of subjects: 106
Study 6766269 — intervention group
Group type: EXPERIMENTAL
Intervention: Starr‐Edwards ball valve type 1200
Number of subjects: 449
Study 6766269 — intervention group
Group type: EXPERIMENTAL
Intervention: Starr‐Edwards ball valve type 2300
Number of subjects: 449
Study 6766269 — intervention group
Group type: EXPERIMENTAL
Intervention: Bjork‐Shiley disc valves
Number of subjects: 449
Study 6766269 — intervention group
Group type: EXPERIMENTAL
Intervention: Lillehei‐Kaster disc valves
Number of subjects: 449
Study 6766269 — intervention group
Group type: EXPERIMENTAL
Intervention: All valve types
Number of subjects: 449
Study 6766269 — intervention group
Group type: EXPERIMENTAL
Intervention: Smaller ball valves
Number of subjects: 449
Study 6766269 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger valves of all types
Number of subjects: 449
Study 6766269 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier valve replacement
Number of subjects: 449
Study 29715369 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG/PG QID (four times daily)
Number of subjects: 97
Study 29715369 — intervention group
Group type: COMPARATOR
Intervention: PEG/PG PRN (as-needed)
Number of subjects: 97
Study 29715369 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG/PG QID
Number of subjects: 97
Study 29715369 — intervention group
Group type: COMPARATOR
Intervention: PEG/PG PRN
Number of subjects: 97
Study 27389475 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab and radiotherapy (CRT)
Number of subjects: 168
Study 27389475 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 168
Study 24556308 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast staining on CT after DSA
Number of subjects: 67
Study 24556308 — intervention group
Group type: COMPARATOR
Intervention: No contrast staining on CT after DSA
Number of subjects: 67
Study 22210721 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasolabial flap (group A)
Number of subjects: 60
Study 22210721 — intervention group
Group type: COMPARATOR
Intervention: Island flap (group B)
Number of subjects: 60
Study 20384673 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2 g/day
Number of subjects: 38
Study 20384673 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) 7.5 mg/week
Number of subjects: 38
Study 18669515 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterical personality traits (object-dependence/ambivalence, egoism)
Number of subjects: 1306
Study 18669515 — intervention group
Group type: COMPARATOR
Intervention: Emotional suppression traits (unfulfilled needs for acceptance, altruism, rationalizing conflicts/frustrations)
Number of subjects: 1306
Study 18669515 — intervention group
Group type: COMPARATOR
Intervention: Loss-hopelessness traits (low sense of control, object-dependence/loss, object-dependence/happiness)
Number of subjects: 1306
Study 15670536 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine 400 mg three times daily
Number of subjects: 158
Study 15670536 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg/day
Number of subjects: 158
Study 15670536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 12055816 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole prophylaxis
Number of subjects: 0
Study 12055816 — intervention group
Group type: COMPARATOR
Intervention: Anti-TB therapy alone
Number of subjects: 0
Study 10490151 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional Anesthesia and Analgesia (RAA) program
Number of subjects: 100
Study 7589641 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg-2.5 mg E2-nomegestrol acetate combination
Number of subjects: 57
Study 7589641 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg-3.75 mg E2-nomegestrol acetate combination
Number of subjects: 57
Study 7589641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 1883123 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 6
Study 1883123 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin
Number of subjects: 6
Study 1883123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 6751176 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg terbutaline
Number of subjects: 24
Study 6751176 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg metaproterenol
Number of subjects: 24
Study 6751176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31277446 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet with 2-3 weekly servings of fresh, lean pork (MedPork)
Number of subjects: 35
Study 31277446 — intervention group
Group type: COMPARATOR
Intervention: Low-fat (LF) control diet
Number of subjects: 35
Study 28893187 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual task (DT) managing balance training, 12 sessions, 60 min each, over 12 weeks
Number of subjects: 95
Study 28893187 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-training)
Number of subjects: 95
Study 28893187 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual task (DT) managing balance training
Number of subjects: 95
Study 26631210 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform system
Number of subjects: 0
Study 26631210 — intervention group
Group type: COMPARATOR
Intervention: Control group (stem removal)
Number of subjects: 0
Study 26055445 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion and Motivation Self‐regulation Questionnaire (EMSR‐Q)
Number of subjects: 664
Study 26055445 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation styles as predictors
Number of subjects: 664
Study 22415333 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine treatment
Number of subjects: 160
Study 22415333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 19714267 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Immersion (VRI)
Number of subjects: 24
Study 19714267 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual Distraction (AVD)
Number of subjects: 24
Study 17724493 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-adjusted lutein and zeaxanthin intake
Number of subjects: 254
Study 17724493 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-adjusted omega-3 fatty acid intake (modelled as a quintile median)
Number of subjects: 254
Study 17724493 — intervention group
Group type: COMPARATOR
Intervention: Total fat and other fat subgroups (saturated, polyunsaturated, monounsaturated, trans fatty acids, omega-6 fatty acids)
Number of subjects: 254
Study 16015596 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH-DT vaccine administered intramuscularly on weeks 1, 3, and 7
Number of subjects: 12
Study 16015596 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel infused intravenously on day 1 of weeks 1, 4, 7, and 10
Number of subjects: 12
Study 16015596 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent treatment with docetaxel and GnRH-DT vaccine
Number of subjects: 12
Study 16015596 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel with high-dose dexamethasone
Number of subjects: 12
Study 16015596 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH-DT vaccine
Number of subjects: 12
Study 11835120 — intervention group
Group type: EXPERIMENTAL
Intervention: Technosphere/Insulin (TI) via inhalation
Number of subjects: 5
Study 11835120 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous regular human insulin (HI)
Number of subjects: 5
Study 10049414 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg twice daily) and Rowachol (2 tablets 3 times daily)
Number of subjects: 20
Study 10049414 — intervention group
Group type: COMPARATOR
Intervention: No drug treatment (control group)
Number of subjects: 20
Study 10049414 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and Rowachol
Number of subjects: 20
Study 7586262 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-eluting lead (Medtronic model 4068)
Number of subjects: 0
Study 7586262 — intervention group
Group type: COMPARATOR
Intervention: Control lead (Medtronic model 4058)
Number of subjects: 0
Study 7586262 — intervention group
Group type: EXPERIMENTAL
Intervention: Both leads
Number of subjects: 0
Study 2338106 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy without any antiemetic treatment
Number of subjects: 849
Study 2338106 — intervention group
Group type: COMPARATOR
Intervention: Visual analogue scale (VAS)
Number of subjects: 849
Study 2338106 — intervention group
Group type: COMPARATOR
Intervention: Discrete scale (DS)
Number of subjects: 849
Study 2338106 — intervention group
Group type: COMPARATOR
Intervention: Continuous chromatic analogue scale (ACCS)
Number of subjects: 849
Study 2338106 — intervention group
Group type: EXPERIMENTAL
Intervention: Nausea dimensions (Q, E, MI)
Number of subjects: 849
Study 111546 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactinex (Lactobacillus acidophilus and L bulgaricus), 1 packet four times daily for the first five days of ampicillin therapy
Number of subjects: 79
Study 111546 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 1 packet four times daily for the first five days of ampicillin therapy
Number of subjects: 79
Study 111546 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactinex (Lactobacillus acidophilus and L bulgaricus)
Number of subjects: 79
Study 111546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 30173369 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted workplace intervention (participatory ergonomics, physical training, cognitive-behavioral training)
Number of subjects: 420
Study 28665468 — intervention group
Group type: EXPERIMENTAL
Intervention: Right arm peripherally inserted central catheters (PICCs)
Number of subjects: 202
Study 28665468 — intervention group
Group type: COMPARATOR
Intervention: Left arm peripherally inserted central catheters (PICCs)
Number of subjects: 202
Study 26076180 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D high-definition imaging system
Number of subjects: 80
Study 26076180 — intervention group
Group type: COMPARATOR
Intervention: 2D high-definition imaging system
Number of subjects: 80
Study 24131736 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-04360365 (0.1, 0.5, 1, 5, or 10 mg/kg)
Number of subjects: 30
Study 24131736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 21288598 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferasirox (20 mg/kg)
Number of subjects: 8
Study 21288598 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 19850703 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart twice daily
Number of subjects: 708
Study 19850703 — intervention group
Group type: EXPERIMENTAL
Intervention: Prandial insulin aspart three times daily
Number of subjects: 708
Study 19850703 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin detemir once daily (twice if required)
Number of subjects: 708
Study 18020110 — intervention group
Group type: COMPARATOR
Intervention: Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)
Number of subjects: 0
Study 18020110 — intervention group
Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 0
Study 18020110 — intervention group
Group type: COMPARATOR
Intervention: N-methyl-D-aspartate receptor antagonist (memantine)
Number of subjects: 0
Study 18020110 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-modifying treatments
Number of subjects: 0
Study 14678954 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric inhibitory polypeptide (GIP) infusion (2 pmol.kg(‐1).min(‐1))
Number of subjects: 15
Study 14678954 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 15
Study 14678954 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP infusion
Number of subjects: 15
Study 11434175 — intervention group
Group type: EXPERIMENTAL
Intervention: High neuroticism group
Number of subjects: 121
Study 11434175 — intervention group
Group type: COMPARATOR
Intervention: Low neuroticism group
Number of subjects: 121
Study 11434175 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurotic boys
Number of subjects: 121
Study 11434175 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurotic girls
Number of subjects: 121
Study 9892909 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment (50 microg/g)
Number of subjects: 58
Study 9892909 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone dipropionate (64 mg/g) and salicylic acid (0.03 g/g) ointment
Number of subjects: 58
Study 8070028 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide phosphate (EP) given at maximum tolerated doses of 100 mg/m2 (daily for 5 days) and 150 mg/m2 (on days 1, 3, and 5)
Number of subjects: 0
Study 8070028 — intervention group
Group type: COMPARATOR
Intervention: Etoposide phosphate (EP)
Number of subjects: 0
Study 3054047 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine delivered into periodontal pockets
Number of subjects: 0
Study 3054047 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole delivered into periodontal pockets
Number of subjects: 0
Study 3054047 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline delivered into periodontal pockets
Number of subjects: 0
Study 3054047 — intervention group
Group type: EXPERIMENTAL
Intervention: Root planing
Number of subjects: 0
Study 3054047 — intervention group
Group type: COMPARATOR
Intervention: Untreated sites
Number of subjects: 0
Study 30020092 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based games (Xbox 360 Kinect) for 3 days/week for 8 weeks
Number of subjects: 62
Study 30020092 — intervention group
Group type: COMPARATOR
Intervention: Activities of daily living practiced using real materials
Number of subjects: 62
Study 28854725 — intervention group
Group type: EXPERIMENTAL
Intervention: Registered trials
Number of subjects: 693
Study 28854725 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospectively registered trials
Number of subjects: 693
Study 28854725 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials registered within 6 months of first patient enrolment
Number of subjects: 693
Study 28854725 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospectively registered trials
Number of subjects: 693
Study 28854725 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective trial registration by country
Number of subjects: 693
Study 25682703 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention for children
Number of subjects: 95
Study 25682703 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 95
Study 23701860 — intervention group
Group type: EXPERIMENTAL
Intervention: LATERAL board
Number of subjects: 13